Klin Onkol 2019; 32(Suppl 3): 13-18.
DOI: 10.14735/amko20193S13.
Keywords: CRISPR-Cas9 – immunotherapy – clinical trial
Authors: Zatloukalová Pavlína, Krejčíř Radovan, Valík Dalibor, Vojtěšek Bořivoj2019-10-14:CRISPR-Cas9 as a Tool in Cancer Therapy
Keywords: CRISPR-Cas9 – immunotherapy – clinical trial
Authors: Zatloukalová Pavlína, Krejčíř Radovan, Valík Dalibor, Vojtěšek Bořivoj2019-10-14:CRISPR-Cas9 as a Tool in Cancer Therapy
Klin Onkol 2019; 32(Suppl 3): 19-24.
DOI: 10.14735/amko20193S19.
Keywords: synthetic lethality – PARP inhibitors – olaparib – BRCAness – DNA repair
Authors: Bortlíková Lucie, Müller Petr, Vojtěšek Bořivoj, Rak Vladimír, Svoboda Marek2019-10-14:Synthetic Lethality – Its Current Application and Potential in Oncological Treatment
Keywords: synthetic lethality – PARP inhibitors – olaparib – BRCAness – DNA repair
Authors: Bortlíková Lucie, Müller Petr, Vojtěšek Bořivoj, Rak Vladimír, Svoboda Marek2019-10-14:Synthetic Lethality – Its Current Application and Potential in Oncological Treatment
Klin Onkol 2019; 32(Suppl 3): 25-33.
DOI: 10.14735/amko20193S25.
Keywords: cancer – chemotherapy – drugs – organometallic compounds – titanium – ruthenium
Authors: Skoupilová Hana, Hrstka Roman2019-10-14:Progress in the Utilisation of Organometallic Compounds in the Development of Cancer Drugs
Keywords: cancer – chemotherapy – drugs – organometallic compounds – titanium – ruthenium
Authors: Skoupilová Hana, Hrstka Roman2019-10-14:Progress in the Utilisation of Organometallic Compounds in the Development of Cancer Drugs
Klin Onkol 2019; 32(Suppl 3): 34-38.
DOI: 10.14735/amko20193S34.
Keywords: signal transduction – breast neoplasms – oestrogen receptors
Authors: Voňka Petr, Hrstka Roman2019-10-14:Overview of Current Findings about the Role of Oestrogen Receptor α in Cancer Cell Signalling Pathways
Keywords: signal transduction – breast neoplasms – oestrogen receptors
Authors: Voňka Petr, Hrstka Roman2019-10-14:Overview of Current Findings about the Role of Oestrogen Receptor α in Cancer Cell Signalling Pathways
Klin Onkol 2019; 32(Suppl 3): 39-45.
DOI: 10.14735/amko20193S39.
Keywords: glycoproteins – serum – biomarkers – cancer
Authors: Hernychová Lenka, Uhrík Lukáš, Nenutil Rudolf, Novotný Miloš2019-10-14:Glycoproteins in the Sera of Oncological Patients
Keywords: glycoproteins – serum – biomarkers – cancer
Authors: Hernychová Lenka, Uhrík Lukáš, Nenutil Rudolf, Novotný Miloš2019-10-14:Glycoproteins in the Sera of Oncological Patients
Klin Onkol 2019; 32(Suppl 3): 46-55.
DOI: 10.14735/amko20193S46.
Keywords: antibodies – glycosylation – pharmacology – immune system – therapeutics
Authors: Uhrík Lukáš, Hernychová Lenka, Vojtěšek Bořivoj2019-10-14:Glycosylation as an Important Regulator of Antibody Function
Keywords: antibodies – glycosylation – pharmacology – immune system – therapeutics
Authors: Uhrík Lukáš, Hernychová Lenka, Vojtěšek Bořivoj2019-10-14:Glycosylation as an Important Regulator of Antibody Function
Klin Onkol 2019; 32(Suppl 3): 56-64.
DOI: 10.14735/amko20193S56.
Keywords: ubiquitin – mass spectrometry – neoplasms – proteins – proteomics
Authors: Faktor Jakub, Pjechová Mariana, Hernychová Lenka, Vojtěšek Bořivoj2019-10-14:Protein Ubiquitination Research in Oncology
Keywords: ubiquitin – mass spectrometry – neoplasms – proteins – proteomics
Authors: Faktor Jakub, Pjechová Mariana, Hernychová Lenka, Vojtěšek Bořivoj2019-10-14:Protein Ubiquitination Research in Oncology
Klin Onkol 2019; 32(Suppl 3): 65-71.
DOI: 10.14735/amko20193S65.
Keywords: long non-coding RNA – tumor biomarkers – carcinogenesis – biosensing techniques
Authors: Moráňová Ludmila, Bartošík Martin2019-10-14:Long Non-Coding RNAs – Current Methods of Detection and Clinical Applications
Keywords: long non-coding RNA – tumor biomarkers – carcinogenesis – biosensing techniques
Authors: Moráňová Ludmila, Bartošík Martin2019-10-14:Long Non-Coding RNAs – Current Methods of Detection and Clinical Applications
Klin Onkol 2019; 32(Suppl 3): 72-77.
DOI: 10.14735/amko20193S72.
Keywords: viry – virové proteiny – p53 – p63 – p73 – tumorigeneze
Authors: Brychtová Veronika, Hrabal Václav, Vojtěšek Bořivoj2019-10-14:Oncogenic Viral Protein Interactions with p53 Family Proteins
Keywords: viry – virové proteiny – p53 – p63 – p73 – tumorigeneze
Authors: Brychtová Veronika, Hrabal Václav, Vojtěšek Bořivoj2019-10-14:Oncogenic Viral Protein Interactions with p53 Family Proteins
Klin Onkol 2019; 32(Suppl 3): 78-85.
DOI: 10.14735/amko20193S78.
Keywords: genomics – transcriptomics – proteomics – bioinformatics – software development
Authors: Zavadil Kokáš Filip, Faktor Jakub, Vojtěšek Bořivoj2019-10-14:Cooperation of Genomic, Transcriptomics and Proteomic Methods in the Detection of Mutated Proteins
Keywords: genomics – transcriptomics – proteomics – bioinformatics – software development
Authors: Zavadil Kokáš Filip, Faktor Jakub, Vojtěšek Bořivoj2019-10-14:Cooperation of Genomic, Transcriptomics and Proteomic Methods in the Detection of Mutated Proteins
Klin Onkol 2019; 32(Suppl 2): 6-13.
DOI: 10.14735/amko2019S6.
Keywords: genes – BRCA1 – BRCA2 – genetic testing – prophylactic mastectomy – salpingo-oophorectomy – high-throughput nucleotide sequencing
Authors: Foretová Lenka, Navrátilová Marie, Svoboda Marek, Vašíčková Petra, Sťahlová Hrabincová Eva, Házová Jana, Kleiblová Petra, Kleibl Zdeněk, Macháčková Eva, Palácová Markéta, Petráková Katarína2019-08-18:Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer
Keywords: genes – BRCA1 – BRCA2 – genetic testing – prophylactic mastectomy – salpingo-oophorectomy – high-throughput nucleotide sequencing
Authors: Foretová Lenka, Navrátilová Marie, Svoboda Marek, Vašíčková Petra, Sťahlová Hrabincová Eva, Házová Jana, Kleiblová Petra, Kleibl Zdeněk, Macháčková Eva, Palácová Markéta, Petráková Katarína2019-08-18:Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer
Klin Onkol 2019; 32(Suppl 2): 14-23.
DOI: 10.14735/amko2019S14.
Keywords: hereditary cancer syndromes – autozomal recessive inheritance – heterozygote – mutation – risk of cancer – predictive testing
Authors: Koudová Monika, Puchmajerová Alena2019-08-18:Risks of Solid Tumors in Heterozygous Carriers of Recessive Syndromes
Keywords: hereditary cancer syndromes – autozomal recessive inheritance – heterozygote – mutation – risk of cancer – predictive testing
Authors: Koudová Monika, Puchmajerová Alena2019-08-18:Risks of Solid Tumors in Heterozygous Carriers of Recessive Syndromes
Klin Onkol 2019; 32(Suppl 2): 23-27.
DOI: 10.14735/amko2019S23.
Keywords: genetic testing – hereditary cancer syndromes – DICER1 – pleuropulmonary blastoma – cystic nephroma
Authors: Hořínová Věra, Drábová Klára, Nosková Hana, Bajčiová Viera, Šoukalová Jana, Černá Leona, Hůrková Věra, Slabý Ondřej, Štěrba Jaroslav2019-08-18:DICER1 Syndrome
Keywords: genetic testing – hereditary cancer syndromes – DICER1 – pleuropulmonary blastoma – cystic nephroma
Authors: Hořínová Věra, Drábová Klára, Nosková Hana, Bajčiová Viera, Šoukalová Jana, Černá Leona, Hůrková Věra, Slabý Ondřej, Štěrba Jaroslav2019-08-18:DICER1 Syndrome
Klin Onkol 2019; 32(Suppl 2): 24-30.
DOI: 10.14735/amko2019S24.
Keywords: breast cancer – BRCA1/2 mutation – genomic tests – platinum salts – PARP inhibitors
Authors: Palácová Markéta2019-08-18:Breast Cancer in BRCA1/2 Mutation Carriers – Do We Treat It Differently? Focus on Systemic Therapy for BRCA1/2 Associated Breast Cancer
Keywords: breast cancer – BRCA1/2 mutation – genomic tests – platinum salts – PARP inhibitors
Authors: Palácová Markéta2019-08-18:Breast Cancer in BRCA1/2 Mutation Carriers – Do We Treat It Differently? Focus on Systemic Therapy for BRCA1/2 Associated Breast Cancer
Klin Onkol 2019; 32(Suppl 2): 31-35.
DOI: 10.14735/amko2019S31.
Keywords: breast cancer – genes, BRCA1 – genes, BRCA2 – neoadjuvant therapy – cisplatin – carboplatin – pathologic complete response
Authors: Holánek Miloš, Bílek Ondřej, Nenutil Rudolf, Kazda Tomáš, Selingerová Iveta, Zvaríková Mária, Palácová Markéta, Vyzula Rostislav, Petráková Katarína2019-08-18:Effectiveness of Neoadjuvant Therapy with Platinum-Based Agents for Patients with BRCA1 and BRCA2 Germline Mutations – A Retrospective Analysis of Breast Cancer Patients Treated at MMCI Brno
Keywords: breast cancer – genes, BRCA1 – genes, BRCA2 – neoadjuvant therapy – cisplatin – carboplatin – pathologic complete response
Authors: Holánek Miloš, Bílek Ondřej, Nenutil Rudolf, Kazda Tomáš, Selingerová Iveta, Zvaríková Mária, Palácová Markéta, Vyzula Rostislav, Petráková Katarína2019-08-18:Effectiveness of Neoadjuvant Therapy with Platinum-Based Agents for Patients with BRCA1 and BRCA2 Germline Mutations – A Retrospective Analysis of Breast Cancer Patients Treated at MMCI Brno